↓ Skip to main content

Susceptibility or resistance of praziquantel in human schistosomiasis: a review

Overview of attention for article published in Parasitology Research, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
307 Dimensions

Readers on

mendeley
377 Mendeley
Title
Susceptibility or resistance of praziquantel in human schistosomiasis: a review
Published in
Parasitology Research, October 2012
DOI 10.1007/s00436-012-3151-z
Pubmed ID
Authors

Wei Wang, Li Wang, You-Sheng Liang

Abstract

Since praziquantel was developed in 1970s, it has replaced other antischistosomal drugs to become the only drug of choice for treatment of human schistosomiases, due to high efficacy, excellent tolerability, few and transient side effects, simple administration, and competitive cost. Praziquantel-based chemotherapy has been involved in the global control strategy of the disease and led to the control strategy shifting from disease control to morbidity control, which has greatly reduced the prevalence and intensity of infections. Given that the drug has been widely used for morbidity control in endemic areas for more than three decades, the emergence of resistance of Schistosoma to praziquantel under drug selection pressure has been paid much attention. It is possible to induce resistance of Schistosoma mansoni and Schistosoma japonicum to praziquantel in mice under laboratorial conditions, and a reduced susceptibility to praziquantel in the field isolates of S. mansoni has been found in many foci. In addition, there are several schistosomiasis cases caused by Schistosoma haematobium infections in which repeated standard treatment fails to clear the infection. However, in the absence of exact mechanisms of action of praziquantel, the mechanisms of drug resistance in schistosomes remain unclear. The present review mainly demonstrates the evidence of drug resistance in the laboratory and field and the mechanism of praziquantel resistance and proposes some strategies for control of praziquantel resistance in schistosomes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 377 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 6 2%
Netherlands 1 <1%
France 1 <1%
Zimbabwe 1 <1%
Switzerland 1 <1%
Ecuador 1 <1%
United Kingdom 1 <1%
Russia 1 <1%
United States 1 <1%
Other 0 0%
Unknown 363 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 58 15%
Student > Master 56 15%
Student > Bachelor 46 12%
Researcher 42 11%
Other 20 5%
Other 63 17%
Unknown 92 24%
Readers by discipline Count As %
Agricultural and Biological Sciences 71 19%
Medicine and Dentistry 39 10%
Biochemistry, Genetics and Molecular Biology 37 10%
Chemistry 35 9%
Pharmacology, Toxicology and Pharmaceutical Science 21 6%
Other 66 18%
Unknown 108 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2014.
All research outputs
#2,209,438
of 22,684,168 outputs
Outputs from Parasitology Research
#77
of 3,772 outputs
Outputs of similar age
#15,749
of 173,108 outputs
Outputs of similar age from Parasitology Research
#1
of 27 outputs
Altmetric has tracked 22,684,168 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,772 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,108 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.